Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
MSC Industrial Direct
MSM
$6.86B
| $5.83M | ﹤0.01% |
71,369
+16,329
| +30% | +$1.33M |
|
1502
CALL
AngloGold Ashanti
AU
$48.7B
| $5.83M | ﹤0.01% |
+300,000
| New | +$4.92M |
|
1503
PUT
ServiceNow
NOW
$129B
| $5.82M | ﹤0.01% |
+75,000
| New | +$5.86M |
|
1504
Vistra
VST
$47.4B
| $5.82M | ﹤0.01% |
250,788
-94,317
| -27% | -$2.18M |
|
|
KRTX
1505
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $5.79M | ﹤0.01% |
29,445
-1,653
| -5% | -$354K |
|
1506
CALL
Invesco Solar ETF
TAN
$1.49B
| $5.78M | ﹤0.01% |
+79,200
| New | +$5.97M |
|
|
ROIC
1507
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $5.78M | ﹤0.01% |
384,293
-66,935
| -15% | -$981K |
|
1508
Ultragenyx Pharmaceutical
RARE
$2.55B
| $5.77M | ﹤0.01% |
124,587
+8,997
| +8% | +$354K |
|
1509
Teck Resources
TECK
$32.6B
| $5.75M | ﹤0.01% |
151,960
-45,568
| -23% | -$1.58M |
|
|
CALY
1510
Callaway Golf Company
CALY
$3.14B
| $5.74M | ﹤0.01% |
290,503
+30,808
| +12% | +$607K |
|
1511
NovoCure
NVCR
$1.91B
| $5.71M | ﹤0.01% |
77,886
+1,975
| +3% | +$149K |
|
1512
CALL
VanEck Junior Gold Miners ETF
GDXJ
$8.46B
| $5.7M | ﹤0.01% |
160,000
| – | – |
|
1513
Magna International
MGA
$18.8B
| $5.7M | ﹤0.01% |
101,501
-80,712
| -44% | -$4.53M |
|
1514
PUT
PayPal
PYPL
$50.5B
| $5.7M | ﹤0.01% |
80,000
| – | – |
|
|
RVNC
1515
DELISTED
Revance Therapeutics, Inc.
RVNC
| $5.7M | ﹤0.01% |
308,564
+214,634
| +229% | +$4.91M |
|
1516
Strategy Inc
MSTR
$38.4B
| $5.69M | ﹤0.01% |
402,030
+107,050
| +36% | +$2.19M |
|
1517
PUT
Range Resources
RRC
$8.95B
| $5.68M | ﹤0.01% |
+227,200
| New | +$6.22M |
|
1518
iShares MSCI Japan ETF
EWJ
$23B
| $5.68M | ﹤0.01% |
104,402
-2,438
| -2% | -$128K |
|
1519
CALL
Kohl's
KSS
$2.19B
| $5.68M | ﹤0.01% |
+225,000
| New | +$6.38M |
|
|
AKRO
1520
DELISTED
Akero Therapeutics
AKRO
| $5.67M | ﹤0.01% |
103,552
+102,364
| +8,616% | +$4.39M |
|
1521
CALL
Carnival Corporation Ltd
CCL
$39.7B
| $5.67M | ﹤0.01% |
+703,700
| New | +$6.06M |
|
1522
BHP
BHP
$230B
| $5.67M | ﹤0.01% |
91,353
-49,241
| -35% | -$2.77M |
|
1523
CALL
Freeport-McMoran
FCX
$97.5B
| $5.66M | ﹤0.01% |
+148,900
| New | +$5.2M |
|
1524
Leslie's
LESL
$11M
| $5.65M | ﹤0.01% |
23,140
+15,854
| +218% | +$4.41M |
|
|
ZEO
1525
Zeo Energy
ZEO
$20.6M
| $5.65M | ﹤0.01% |
546,254
| – | – |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.